PillRx only · Tablet, Delayed Release · Oral
Acamprosate Calcium Enteric-Coated
Acamprosate Calcium
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US2 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers2 labelers
Packages2
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.608
Latest avg · Jun 17, 2026
+2%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*
Who makes it1 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Mylan Pharmaceuticals Inc. | unknown | 1 | SUPPLYING |
| NCS HealthCare of KY, LLC dba Vangard Labs | unknown | 1 | EXITED 2026 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.